Abstract
The disproportionate emphasis on discovery research in genetics and genomics needs to be balanced by new approaches to funding translational research, development of evidence-based clinical guidelines, and robust regulation of genetic tests. These measures will help ensure that patients, providers, and others are better able to discriminate between valid genomic applications that can improve public health and those that are not useful and potentially harmful. Doing so will require that we dispense with models of research support and regulatory guidance designed for the pre-Human Genome Project world, and replace them with policies and programs as innovative as genetics research itself has been.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
